Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Alterity Therapeutics Ltd (NASDAQ:PRAN.DL)

CAPS Rating: No stars

The Company develops therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer's disease.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:PRAN.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Crystalball (52.52)
Submitted March 31, 2014

Wow, I can't resist the chance to load up after a sell off like this one. Shares will recover with time.

asilverp (95.29)
Submitted August 28, 2014

dubious company with even more dubious statistics. High probability of it being a long term loser.

NASDAQ:PRAN.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about PRAN.DL.

No one has written a Pitch for PRAN.DL stock yet. Tell us why you think PRAN.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in PRAN.DL.

No players have picked PRAN.DL yet. Tell us why you think PRAN.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PRAN.DL.